| Dr Harry James Dounis, DO | |
|
2100 Corlies Ave, Suite 15, Neptune, NJ 07753-6102 | |
| (732) 988-8228 | |
| Not Available |
| Full Name | Dr Harry James Dounis |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 19 Years |
| Location | 2100 Corlies Ave, Neptune, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124286083 | NPI | - | NPPES |
| 0379859 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 25MB08752800 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Dci Freehold | Freehold, NJ | Dialysis facility |
| Dva Freehold Akc | Manalapan, NJ | Dialysis facility |
| Physicians Dialysis Brick | Brick, NJ | Dialysis facility |
| Centrastate Medical Center | Freehold, NJ | Hospital |
| Jersey Shore University Medical Center | Neptune, NJ | Hospital |
| Ocean Medical Center | Brick, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Shore Nephrology Pa | 7113993460 | 6 |
News Archive
Alexion Pharmaceuticals, Inc. today announced that the Company has completed its previously announced acquisition of 100% of the capital stock of Enobia Pharma Corp., a private biopharmaceutical company focused on the development of therapies to treat patients with ultra-rare and life-threatening genetic metabolic disorders.
An organized population-based breast cancer screening program in Norway and an approach to screening that relies on physician- and self-referrals in Vermont are equally sensitive for detecting cancer, researchers report in the July 29 online issue of the Journal of the National Cancer Institute. But the recall rate for abnormal mammograms was lower in Norway.
According to new research from the U.S. controlling the level of a fatty acid in the brain could help treat Alzheimer's disease (AD).
Millions of the world's poorest people are suffering needlessly from diseases that are being neglected because of the emphasis given to the "big 3" killers, HIV/AIDS, TB and Malaria, says Professor David Molyneux of the Liverpool School of Tropical Medicine.
› Verified 7 days ago
| Entity Name | Shore Nephrology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003926171 PECOS PAC ID: 7113993460 Enrollment ID: O20040908000563 |
News Archive
Alexion Pharmaceuticals, Inc. today announced that the Company has completed its previously announced acquisition of 100% of the capital stock of Enobia Pharma Corp., a private biopharmaceutical company focused on the development of therapies to treat patients with ultra-rare and life-threatening genetic metabolic disorders.
An organized population-based breast cancer screening program in Norway and an approach to screening that relies on physician- and self-referrals in Vermont are equally sensitive for detecting cancer, researchers report in the July 29 online issue of the Journal of the National Cancer Institute. But the recall rate for abnormal mammograms was lower in Norway.
According to new research from the U.S. controlling the level of a fatty acid in the brain could help treat Alzheimer's disease (AD).
Millions of the world's poorest people are suffering needlessly from diseases that are being neglected because of the emphasis given to the "big 3" killers, HIV/AIDS, TB and Malaria, says Professor David Molyneux of the Liverpool School of Tropical Medicine.
› Verified 7 days ago
| Entity Name | Kidney Care Centers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689302424 PECOS PAC ID: 6204279441 Enrollment ID: O20240205003466 |
News Archive
Alexion Pharmaceuticals, Inc. today announced that the Company has completed its previously announced acquisition of 100% of the capital stock of Enobia Pharma Corp., a private biopharmaceutical company focused on the development of therapies to treat patients with ultra-rare and life-threatening genetic metabolic disorders.
An organized population-based breast cancer screening program in Norway and an approach to screening that relies on physician- and self-referrals in Vermont are equally sensitive for detecting cancer, researchers report in the July 29 online issue of the Journal of the National Cancer Institute. But the recall rate for abnormal mammograms was lower in Norway.
According to new research from the U.S. controlling the level of a fatty acid in the brain could help treat Alzheimer's disease (AD).
Millions of the world's poorest people are suffering needlessly from diseases that are being neglected because of the emphasis given to the "big 3" killers, HIV/AIDS, TB and Malaria, says Professor David Molyneux of the Liverpool School of Tropical Medicine.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Harry James Dounis, DO 2100 Corlies Ave, Suite 15, Neptune, NJ 07753-6102 Ph: (732) 988-8228 | Dr Harry James Dounis, DO 2100 Corlies Ave, Suite 15, Neptune, NJ 07753-6102 Ph: (732) 988-8228 |
News Archive
Alexion Pharmaceuticals, Inc. today announced that the Company has completed its previously announced acquisition of 100% of the capital stock of Enobia Pharma Corp., a private biopharmaceutical company focused on the development of therapies to treat patients with ultra-rare and life-threatening genetic metabolic disorders.
An organized population-based breast cancer screening program in Norway and an approach to screening that relies on physician- and self-referrals in Vermont are equally sensitive for detecting cancer, researchers report in the July 29 online issue of the Journal of the National Cancer Institute. But the recall rate for abnormal mammograms was lower in Norway.
According to new research from the U.S. controlling the level of a fatty acid in the brain could help treat Alzheimer's disease (AD).
Millions of the world's poorest people are suffering needlessly from diseases that are being neglected because of the emphasis given to the "big 3" killers, HIV/AIDS, TB and Malaria, says Professor David Molyneux of the Liverpool School of Tropical Medicine.
› Verified 7 days ago
Hani Naser, Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1945 State Route 33, Neptune, NJ 07753 Phone: 732-776-4483 Fax: 732-776-4798 | |
Dr. Adam Chaim Kaplan, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 19 Davis Ave Fl 6, Neptune, NJ 07753 Phone: 732-897-3990 Fax: 732-897-3997 | |
Jose Fune, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 19 Davis Ave Fl 6, Neptune, NJ 07753 Phone: 732-897-3995 Fax: 732-897-3997 | |
Dr. Daniel Mark Shenouda, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1945 State Route 33, Neptune, NJ 07753 Phone: 908-217-3023 Fax: 732-776-4798 | |
Dr. Kathleen King Casey, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 19 Davis Ave Fl 6, Neptune, NJ 07753 Phone: 732-897-3995 Fax: 732-897-3997 | |
Philip Willie Bankole Clarkson, M.D Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1945 State Route 33, Neptune, NJ 07753 Phone: 732-776-4483 Fax: 732-776-4798 | |
Kelly West Fitzpatrick, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 19 Davis Ave Fl 2, Neptune, NJ 07753 Phone: 732-367-1535 Fax: 732-367-9514 |